Literature DB >> 23168236

DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer.

Flavia Roche Moreira Latini1, André Uchimura Bastos, Carine Prisco Arnoni, Janaína Guilhem Muniz, Rosangela Medeiros Person, Wilson Baleotti, José Augusto Barreto, Lilian Castilho, Janete Maria Cerutti.   

Abstract

Duffy or DARC (Duffy Antigen Receptor for Chemokines) is a glycosylated membrane protein that selectively binds angiogenic chemokines. Previous in vivo and in vitro studies of DARC function in cancer have associated DARC over expression with better prognosis, decreased metastatic potential, and inhibition of tumor-associated neovascularization. Another carcinogenesis-associated antigen is Lutheran or BCAM (basal cell adhesion molecule), a surface glycoprotein that acts as a receptor for the extracellular matrix protein, laminin. BCAM is a protein related to tumor progression; and, its over expression is associated with skin, ovarian and pancreatic cancers. We explored DARC and BCAM functions and investigated whether or not their expressions were altered in thyroid cancer. The expression of DARC and BCAM were evaluated by quantitative real-time PCR (qPCR) in a set of 18 normal thyroid tissues (NT), 15 follicular adenomas (FTA), 17 follicular carcinomas (FTC), and 122 papillary thyroid carcinomas (PTC), including 78 classical (CVPTC) and 44 follicular variant (FVPTC). RNA was isolated, reverse transcribed to cDNA, and used in qPCR reactions containing SYBR Green. The relative expression value was calculated using ribosomal protein S8 as an internal control. When we compared benign (NT and FTA) versus malignant samples (FTC, CVPTC and FVPTC) we observed a significant decrease of DARC and BCAM relative expression in malignant cases. Additionally, we correlated clinic-pathological features (tumor size, presence of metastasis, presence of lymphocyte infiltrate) with DARC and BCAM expression. We found a diminished expression of DARC in PTC samples, which was correlated with tumor size and presence of a lymphocyte infiltrate. We, also, found a correlation between decreased BCAM expression and tumor size or presence of metastasis. DARC and BCAM expression was associated with pathogenesis of thyroid carcinoma and correlated with clinical-pathological features.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168236     DOI: 10.1016/j.bcmd.2012.10.009

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  10 in total

1.  Dimerization and phosphorylation of Lutheran/basal cell adhesion molecule are critical for its function in cell migration on laminin.

Authors:  Anna Guadall; Sylvie Cochet; Olivier Renaud; Yves Colin; Caroline Le Van Kim; Alexandre G de Brevern; Wassim El Nemer
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

2.  Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.

Authors:  Jun Du; Senlian Hong; Lu Dong; Bo Cheng; Liang Lin; Bing Zhao; Ye-Guang Chen; Xing Chen
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

3.  Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.

Authors:  Kwangsik Nho; Sungeun Kim; Emrin Horgusluoglu; Shannon L Risacher; Li Shen; Dokyoon Kim; Seunggeun Lee; Tatiana Foroud; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Ronald C Petersen; Clifford R Jack; Michael W Weiner; Robert C Green; Arthur W Toga; Andrew J Saykin
Journal:  BMC Med Genomics       Date:  2017-05-24       Impact factor: 3.063

4.  The expression of Duffy antigen receptor for chemokines by epithelial ovarian cancer decreases growth potential.

Authors:  Qinyi Zhu; Lu Jiang; Xipeng Wang
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

5.  The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.

Authors:  Hong-Yi Chang; Hsin-Mei Chang; Tsung-Jung Wu; Chang-Yao Chaing; Tzong-Shin Tzai; Hong-Lin Cheng; Giri Raghavaraju; Nan-Haw Chow; Hsiao-Sheng Liu
Journal:  J Biomed Sci       Date:  2017-08-26       Impact factor: 8.410

6.  Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.

Authors:  Junjie Zhao; Jiayu Liang; Yang Yang; Guangxi Sun; Xingming Zhang; Jinge Zhao; Xu Hu; Junru Chen; Sha Zhu; Yuchao Ni; Yaowen Zhang; Jindong Dai; Zhipeng Wang; Zilin Wang; Yuhao Zeng; Jin Yao; Ni Chen; Pengfei Shen; Zhenhua Liu; Hao Zeng
Journal:  Clin Epigenetics       Date:  2022-08-08       Impact factor: 7.259

7.  Apoptosis and tissue thinning contribute to symmetric cell division in the developing mouse epidermis in a nonautonomous way.

Authors:  Arad Soffer; Adnan Mahly; Krishnanand Padmanabhan; Jonathan Cohen; Orit Adir; Eidan Loushi; Yaron Fuchs; Scott E Williams; Chen Luxenburg
Journal:  PLoS Biol       Date:  2022-08-15       Impact factor: 9.593

8.  The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix.

Authors:  Jeremy A Herrera; Lewis Dingle; M Angeles Montero; Rajamiyer V Venkateswaran; John F Blaikley; Craig Lawless; Martin A Schwartz
Journal:  JCI Insight       Date:  2022-08-22

9.  The FBI1/Akirin2 target gene, BCAM, acts as a suppressive oncogene.

Authors:  Hirotada Akiyama; Yoshimasa Iwahana; Mikiya Suda; Atsunori Yoshimura; Hiroyuki Kogai; Ai Nagashima; Hiroko Ohtsuka; Yuko Komiya; Fumio Tashiro
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Traditional Chinese Medicine Extract from Huaier Increases the Expression of Duffy Antigen Receptor for Chemokines and Reduces the Expression of Its Ligands.

Authors:  Ying Chen; Qianjun Chen; Fengfeng Xie; Hui Peng; Yanlan Wu; Shaowen Zhong; Zhiyu Wang; Wenxia Li; Wanjun Xie
Journal:  Anal Cell Pathol (Amst)       Date:  2018-07-24       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.